•  
  •  
  •  
  •  

2026-07-22 03:02:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  IndSwiftLaboratories

Stock Report

  • Ind-Swift Laboratories Earns EcoVadis Silver Medal for Sustainability Excellence
  • Ind-Swift Laboratories allocates ₹40 Cr for Samba Facility Upgrade
  • Ind-Swift Laboratories Ltd receives GMP compliance certificate from NNGYK-Hungary
  • Ind-Swift Laboratories Ltd receives certifications from Bureau Veritas
  • Emerald Finance Ltd partners with Ind-Swift Laboratories Ltd for Early Wage Access program
  • Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
  • Ind-Swift Laboratories Ltd to purchase land for Rs. 12.50 crores
  • Ind Swift Laboratories Limited inaugurates a new marketing office at Nehru Place, New Delhi
  • Ind-Swift Laboratories Ltd consolidated Q4FY24 PAT jumps to Rs. 233.82 crores
  • CMD of IND-SWIFT LABORATORIES LTD conferred with award by IDMA
  • Ind-Swift Laboratories Ltd receives award from World HRD Congress
  • Ind-Swift Laboratories Ltd collaborates with CSIR-IMTECH
  • IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores
  • Ind-Swift Laboratories Ltd Q1 FY24 consolidated PAT at Rs. 17.24 crores
  • Ind-Swift Laboratories wins award
  • Ind-Swift Laboratories Ltd posts consolidated PAT of Rs. 25.34 crores in Q2FY23
  • Ind-Swift Laboratories Ltd posts Rs. 61.45 crores consolidated loss in Q4FY22
  • Ind-Swift Laboratories Q3FY22 consolidated net profit drops QoQ to Rs. 16.02 crores
  • Ind-Swift Laboratories Ltd reports consolidated PAT of Rs. 24.47 crore in Q2FY22

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025